Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Correction: multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
[Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
[Natalizumab as induction therapy in multiple sclerosis.]
SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.
Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis.
Contrast-Enhanced MR Imaging in Neuroimaging.
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
Correction: optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
Celiac disease with cerebral and peripheral nerve involvement mimicking multiple sclerosis.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
Gait variability in people with neurological disorders: A systematic review and meta-analysis.
A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS.

Pages